DC
PFE icon

Davenport & Co’s Pfizer PFE Stock Holding History

Davenport & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
446,366
+1,213
+0.3% +$31.7K 0.05% 247
2026
Q1 		$12.5M Buy
445,153
+6,363
+1% +$169K 0.07% 216
2025
Q4 		$10.9M Buy
438,790
+9,689
+2% +$244K 0.06% 220
2025
Q3 		$10.9M Buy
429,101
+20,637
+5% +$509K 0.06% 222
2025
Q2 		$9.9M Buy
408,464
+29,795
+8% +$695K 0.05% 222
2025
Q1 		$9.59M Buy
378,669
+52,497
+16% +$1.37M 0.06% 224
2024
Q4 		$8.65M Sell
326,172
-34,439
-10% -$934K 0.05% 239
2024
Q3 		$10.4M Buy
360,611
+4,573
+1% +$133K 0.06% 207
2024
Q2 		$9.96M Sell
356,038
-24,446
-6% -$673K 0.06% 204
2024
Q1 		$10.6M Buy
380,484
+35,345
+10% +$981K 0.06% 201
2023
Q4 		$9.94M Sell
345,139
-44,593
-11% -$1.35M 0.07% 187
2023
Q3 		$12.9M Sell
389,732
-6,686
-2% -$236K 0.1% 154
2023
Q2 		$14.5M Buy
396,418
+3,623
+0.9% +$141K 0.11% 149
2023
Q1 		$16M Sell
392,795
-882
-0.2% -$38.1K 0.13% 147
2022
Q4 		$20.2M Buy
393,677
+4,593
+1% +$220K 0.16% 131
2022
Q3 		$17M Buy
389,084
+409
+0.1% +$19.9K 0.15% 134
2022
Q2 		$20.4M Sell
388,675
-28,193
-7% -$1.44M 0.17% 122
2022
Q1 		$21.6M Buy
416,868
+21,339
+5% +$1.11M 0.15% 123
2021
Q4 		$23.4M Sell
395,529
-20,941
-5% -$1.04M 0.15% 122
2021
Q3 		$17.9M Sell
416,470
-44,507
-10% -$1.97M 0.13% 134
2021
Q2 		$18.1M Buy
460,977
+82,048
+22% +$3.19M 0.14% 126
2021
Q1 		$13.7M Sell
378,929
-12,048
-3% -$428K 0.13% 121
2020
Q4 		$14.4M Sell
390,977
-13,129
-3% -$482K 0.14% 118
2020
Q3 		$14.1M Buy
404,106
+23,071
+6% +$809K 0.16% 110
2020
Q2 		$11.8M Buy
381,035
+31,882
+9% +$1.08M 0.14% 114
2020
Q1 		$10.8M Buy
349,153
+3,454
+1% +$118K 0.16% 108
2019
Q4 		$12.9M Buy
345,699
+33,829
+11% +$1.2M 0.14% 115
2019
Q3 		$12.8M Buy
311,870
+948
+0.3% +$34.5K 0.15% 109
2019
Q2 		$12.8M Sell
310,922
-6,425
-2% -$255K 0.15% 108
2019
Q1 		$12.8M Buy
317,347
+5,876
+2% +$235K 0.16% 106
2018
Q4 		$12.9M Buy
311,471
+3,747
+1% +$156K 0.18% 108
2018
Q3 		$12.9M Buy
307,724
+27,130
+10% +$1.04M 0.15% 117
2018
Q2 		$9.66M Buy
280,594
+14,057
+5% +$480K 0.12% 122
2018
Q1 		$8.97M Sell
266,537
-2,879
-1% -$99K 0.11% 125
2017
Q4 		$9.26M Sell
269,416
-4,020
-1% -$137K 0.11% 127
2017
Q3 		$9.26M Sell
273,436
-2,278
-0.8% -$73.2K 0.12% 123
2017
Q2 		$8.79M Sell
275,714
-14,069
-5% -$444K 0.12% 121
2017
Q1 		$8.93M Sell
289,783
-2,364
-0.8% -$74.5K 0.13% 121
2016
Q4 		$9M Buy
292,147
+8,640
+3% +$264K 0.13% 119
2016
Q3 		$9.11M Buy
283,507
+6,745
+2% +$226K 0.13% 117
2016
Q2 		$9.25M Buy
276,762
+29,779
+12% +$950K 0.14% 117
2016
Q1 		$6.95M Sell
246,983
-2,457
-1% -$70.2K 0.11% 124
2015
Q4 		$7.64M Buy
249,440
+3,478
+1% +$109K 0.12% 116
2015
Q3 		$7.33M Buy
245,962
+7,352
+3% +$236K 0.12% 121
2015
Q2 		$7.59M Buy
238,610
+13,096
+6% +$427K 0.12% 128
2015
Q1 		$7.44M Sell
225,514
-3,505
-2% -$111K 0.11% 131
2014
Q4 		$6.77M Buy
229,019
+10,234
+5% +$293K 0.11% 129
2014
Q3 		$6.14M Sell
218,785
-1,739
-0.8% -$48.8K 0.11% 132
2014
Q2 		$6.21M Sell
220,524
-17,438
-7% -$497K 0.11% 133
2014
Q1 		$7.25M Sell
237,962
-1,859
-0.8% -$55.4K 0.13% 124
2013
Q4 		$6.97M Sell
239,821
-236
-0.1% -$6.87K 0.13% 126
2013
Q3 		$6.54M Buy
240,057
+2,935
+1% +$79.9K 0.13% 121
2013
Q2 		$6.3M Buy
+237,122
New +$6.55M 0.14% 112

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co's PFE Position: Q2 2026 in Review

Davenport & Co increased its Pfizer (PFE) stake by 0.27% in Q2 2026, buying an estimated $31.7K and bringing the position to 446,366 shares worth $10.8M. The position accounts for 0.05% of the portfolio, ranked #247.

Davenport & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.4M in Q4 2021. 675 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Davenport & Co held 446,366 shares of Pfizer worth $10.8M as of Q2 2026.
  • Davenport & Co bought 1,213 Pfizer shares in Q2 2026, an estimated $31.7K.
  • Pfizer made up 0.05% of Davenport & Co's portfolio in Q2 2026, its #247 holding.
  • Davenport & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Pfizer position peaked at $23.4M in Q4 2021.
  • 675 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.